HistoSonics Valued at $2.25B After Major Acquisition - Health M&A
Summary by hitconsultant.net
1 Articles
1 Articles
HistoSonics Valued at $2.25B After Major Acquisition - Health M&A
What You Should Know: – HistoSonics, the company behind the non-invasive Edison® Histotripsy System, has announced a management-led majority stake acquisition by a syndicate of private and public investors, including K5 Global, Bezos Expeditions, and Wellington Management. – The transaction values the company at approximately $2.25 billion and is expected to accelerate the growth of its Edison System across new clinical indications and global …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium